MDR3cyte®

MDR3cyte® is a fully-validated assay format that characterizes MDR3 inhibition by a test agent using primary hepatocytes in suspension. This platform is metabolically competent and retains biological functions. The assay involves in situ biosynthesis of deuterium (d9)-labeled PC, activation of MDR3 by bile salt micelles and LC-MS/MS determination of transported extracellular d9-PC. The profile of PCs produced using the MDR3cyte® assay platform and human hepatocyte more accurately reflects the profile found in natural human bile. MDR3 inhibition is associated with most DILI-concern drugs.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

This field is for validation purposes and should be left unchanged.

MDR3cyte®

Resources to Consider

BSEPcyte® and MDR3cyte®: Innovative Solutions for Investigating...